Products 1059-14-9

CAS 1059-14-9 appears in our catalog under these names: Taraxasterol, Taraxasterol/ 99.79% (existing batch purity), (+)-Taraxasterol, Taraxasterol (Standard), Taraxasterol, 95%, 95%. Offered by: Chemat Brand, TargetMol, Biosynth, MedChemExpress, Chemat. Available pack sizes: on request, 1mg, 5mg, 10mg, 25mg, 50mg, 100mg, 250mg.

Taraxasterol
Chemat Brand
  • size: on request
  • Variants: 1
View product
Taraxasterol/ 99.79% (existing batch purity)
TargetMol
  • size: 1mg, 5mg, 10mg, 25mg
  • Variants: 5
from 644.96
View product
(+)-Taraxasterol
Biosynth
  • size: 50mg, 25mg, 100mg, 250mg
  • Variants: 5
View product
Taraxasterol (Standard)
MedChemExpress
  • size: Get quote
  • Variants: 1
View product
Taraxasterol, 95%, 95%
Chemat
  • size: 5mg, 10mg, 20mg, 100mg
  • Variants: 4
from 318.80
View product
Taraxasterol, 99.41%
MedChemExpress
  • size: 5 mg, 10 mg
  • Variants: 2
from 431.15
View product
Taraxasterol, 95%
Fluorochem
  • size: 100mg
  • Variants: 1
from 2976.05
View product
Structural formula: {0} (CAS {1})

Taraxasterol is a pentacyclic triterpenoid that is taraxastane with a beta-hydroxy group at position 3. It has a role as a metabolite and an anti-inflammatory agent. It is a pentacyclic triterpenoid and a secondary alcohol. It derives from a hydride of a taraxastane.

Source: ChEBI

Identity
Molecular formulaC30H50O
Molecular weight426.7 g/mol
IUPAC name(3S,4aR,6aR,6aR,6bR,8aR,12S,12aR,14aR,14bR)-4,4,6a,6b,8a,12,14b-heptamethyl-11-methylidene-1,2,3,4a,5,6,6a,7,8,9,10,12,12a,13,14,14a-hexadecahydropicen-3-ol
InChIKeyXWMMEBCFHUKHEX-ZJJHUPNDSA-N
SMILESC[C@H]1[C@@H]2[C@H]3CC[C@@H]4[C@]5(CC[C@@H](C([C@@H]5CC[C@]4([C@@]3(CC[C@]2(CCC1=C)C)C)C)(C)C)O)C

Computed by PubChem (NCBI)

Synonyms: Taraxasterol, Isolactucerol, alpha-lactucerol, 18alpha,19alpha-urs-20(30)-en-3beta-ol, (3beta,18alpha,19alpha)-urs-20(30)-en-3-ol, anthesterin, 18alpha,19betaH-Urs-20(30)-en-3beta-ol, Saussurol, Urs-20(30)-en-3-ol, (3beta,18alpha,19alpha)-, Lactucerol
Isomers (same molecular formula)
(3S,4aR,6aR,6bS,8aR,12aR,14aR,14bR)-4,4,6a,6b,8a,11,11,14b-octamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-ol C30H50O
(1R,3aR,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-3a,5a,5b,8,8,11a-hexamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysen-9-ol C30H50O
(3S,8R,9R,10S,13R,14S,17R)-4,4,9,13,14-pentamethyl-17-[(2R)-6-methylhept-5-en-2-yl]-2,3,7,8,10,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ol C30H50O
(3S,4S,5S,9R,10S,13R,14R,17R)-4,10,13-trimethyl-17-[(Z,2R)-5-propan-2-ylhept-5-en-2-yl]-2,3,4,5,6,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol C30H50O
(3S)-2,2-dimethyl-3-[(3E,7E,11E,15E)-3,7,12,16,20-pentamethylhenicosa-3,7,11,15,19-pentaenyl]oxirane C30H50O
(3S,4aR,6aR,6bS,8aR,11R,12S,12aR,14aR,14bR)-4,4,6a,6b,8a,11,12,14b-octamethyl-2,3,4a,5,6,7,8,9,10,11,12,12a,14,14a-tetradecahydro-1H-picen-3-ol C30H50O
(1S,3R,6S,8R,11S,12S,15R,16R)-7,7,12,16-tetramethyl-15-[(2R)-6-methylhept-5-en-2-yl]pentacyclo[9.7.0.01,3.03,8.012,16]octadecan-6-ol C30H50O
2,2-dimethyl-3-[(3E,7E,11E,15E)-3,7,12,16,20-pentamethylhenicosa-3,7,11,15,19-pentaenyl]oxirane C30H50O
(4R,4aS,6aS,6aS,6bR,8aR,12aR,14aS,14bS)-4,4a,6a,6b,8a,11,11,14a-octamethyl-2,4,5,6,6a,7,8,9,10,12,12a,13,14,14b-tetradecahydro-1H-picen-3-one C30H50O
(3R,6aS,6aS,6bR,8aR,12aR,14aR,14bS)-4,4,6a,6b,8a,11,11,14a-octamethyl-1,2,3,6,6a,7,8,9,10,12,12a,13,14,14b-tetradecahydropicen-3-ol C30H50O
(3S,4S,5S,10S,13R,14R,17R)-4,10,13,14-tetramethyl-17-[(2R)-6-methyl-5-methylideneheptan-2-yl]-1,2,3,4,5,6,7,11,12,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-ol C30H50O
(3S,5R,10S,13S,14S,17S)-4,4,10,13,14-pentamethyl-17-[(2R)-6-methylhept-5-en-2-yl]-2,3,5,6,7,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ol C30H50O